SCHEMBL21148246

SCHEMBL21148246

c1cc(-c2nc(-c3ccc4sc5ccccc5c4c3)nc(-c3cccc4sc5ccccc5c34)n2)cc(-c2cccc3sc4ccccc4c23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
GPR3 P46089 1/20 0.36
LIMK1 P53667 1/20 0.34
PIM3 Q86V86 1/20 0.34
CYP1A2 P05177 1/20 0.33
BRDT Q58F21 1/20 0.33
MAPT P10636 4/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
POLB P06746 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
F9 P00740 1/20 0.32
MEN1 O00255 1/20 0.32
DUSP3 P51452 1/20 0.32
BLM P54132 1/20 0.32
PTPN5 P54829 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21148603 0.95 ALOX5 (0.39) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL21148613 0.95 GPR3 (0.40) ALOX5GPR3PIM3CYP1A2BRDT
SCHEMBL21149216 0.94 ALOX5 (0.37) ALOX5GPR3PIM3CYP1A2BRDT
SCHEMBL25950494 0.94 PIM3 (0.41) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL25944421 0.94 PIM3 (0.41) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL21149149 0.94 ALOX5 (0.39) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL25730550 0.94 ALOX5 (0.37) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL21149238 0.94 ALOX5 (0.37) ALOX5GPR3LIMK1PIM3CYP1A2
SCHEMBL21148248 0.93 LIMK1 (0.38) ALOX5GPR3LIMK1CYP1A2BRDT
SCHEMBL26080448 0.93 PIM3 (0.39) ALOX5GPR3LIMK1PIM3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885GPR3 1439/4885LIMK1 133/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885GPR3 1439/4885LIMK1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.